Pharmaceutical composition for treating depressive disorder and application thereof

A composition and technology for depression, which are applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, and can solve problems such as unsatisfactory drug treatment effects.

Inactive Publication Date: 2020-06-02
陶燃
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In view of this, the purpose of the present invention is to propose a pharmaceutical composition for the effective treatment of depression through multi-target intervention to solve the unsatisfactory problem of existing drug treatment effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating depressive disorder and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The pharmaceutical composition in this example includes the following drugs by weight: 40 mg of dihydroartemisinin and 0.4 mg of folic acid.

Embodiment 2

[0026] The pharmaceutical composition in this example includes the following drugs by weight: 40 mg of dihydroartemisinin and 0.6 mg of folic acid.

Embodiment 3

[0028] The pharmaceutical composition in this example includes the following drugs by weight: 60 mg of dihydroartemisinin and 0.4 mg of folic acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for treating depressive disorder. The pharmaceutical composition comprises an artemisinin compound and folic acid. According to the invention, the artemisinin compound and the folic acid are combined for the first time to form a novel pharmaceutical composition with an anti-depression effect. The inventor finds that two above-mentioned componentswith different action targets have a mutual synergistic effect, can regulate immunity, resist inflammation and oxidation, improve the level of 5-HT in serum, reduce the content of neurotoxins like serum homocysteine and supplement cell nutrition, and have the anti-depression effect. The pharmaceutical composition provided by the invention shows good anti-depression effect in clinical trials, hasno dependence, has few side effects, is safe and reliable, is low in cost, has easily-available raw materials, and facilitates popularization and application.

Description

technical field [0001] The invention relates to the technical field, in particular to a pharmaceutical composition for treating depression and its application. Background technique [0002] Depression is also known as depressive disorder. According to authoritative department reports: At present, the number of depression patients in China has reached 90 million, and the number of depression patients will reach more than 100 million in 2020. This disease seriously affects human physical and mental health. At present, the treatment of depression mainly uses chemical drugs such as 5-hydroxytryptamine (5-HT) reuptake inhibitors. After clinical application of these drugs, most people have unsatisfactory effects. In addition, they need to be taken for a long time. The burden is eagerly awaiting the emergence of drugs for the treatment of depression in new ways. Contents of the invention [0003] In view of this, the purpose of the present invention is to propose a pharmaceutic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/357A61K31/366A61K31/519A61P25/24
CPCA61K31/357A61K31/366A61K31/519A61P25/24A61K2300/00
Inventor 陶燃
Owner 陶燃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap